Author

Claudio Conrad

EARLY MOLECULAR SIGNATURES OF THERAPEUTIC RESPONSE TO VEDOLIZUMAB THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS IDENTIFIED USING A LONGITUDINAL MULTI-OMICS APPROACH
EARLY MOLECULAR SIGNATURES OF THERAPEUTIC RESPONSE TO VEDOLIZUMAB THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS IDENTIFIED USING A LONGITUDINAL MULTI-OMICS APPROACH

Claudio Conrad  et al.

TRYPTOPHAN DEGRADATION PRODUCTS AS UNIFYING BIOMARKERS OF SEVERITY AND LONG-TERM DISEASE CONTROL IN CHRONIC INFLAMMATORY DISEASES
TRYPTOPHAN DEGRADATION PRODUCTS AS UNIFYING BIOMARKERS OF SEVERITY AND LONG-TERM DISEASE CONTROL IN CHRONIC INFLAMMATORY DISEASES

Claudio Conrad  et al.

Item 1 - 2 / 2
1